Cytokine tissue levels as markers of disease activity in pediatric Crohn disease

Pediatric Research

Volumn 54, Issue 4, 2003, Pages 456-461

  Silva, Manuel A ^a   Menezes, José ^a   Wizman, Sarah ^a   Gendron, Roxanne ^a   Oligny, Luc ^b   Seidman, Ernest G ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; DNA; INTERLEUKIN 15; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; COLON MUCOSA; COLONOSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RECTUM BIOPSY; SCHOOL CHILD; VIRUS INFECTION;

EID: 0141676887     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000083002.91602.40     Document Type: Article

References (48)

1. Watts DA, Satsangi J 2002 The genetic jigsaw of inflammatory bowel disease. Gut 50(suppl III):iii31-iii36
2. Fiocchi C 1998 Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182-205
3. Duff GW 1989 Peptide regulatory factors in non-malignant disease. Lancet 1:1432
4. Choy M, Walker-Smith J, Williams C, MacDonald T 1990 Differential expression of CD 25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis. Gut 31:1365-1370
5. Crabtree JE, Juby LD, Heatley RV, Lobo AJ, Bullimore DW, Axon ATR 1990 Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity. Gut 31:1033-1036
6. Mahida YR, Gallagher A, Kurlak L, Hawkey CJ 1990 Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease. Clin Exp Immunol 82:75-80
7. Mueller Ch, Knoflach P, Zielinski CC 1990 T-cell activation in Crohn's disease. Gastroenterology 98:639-646
8. Williams A, Symons J, Watchet K, Duff GW 1992 Soluble interleukin-2 receptor and disease activity in Crohn's disease. J Autoimmun 5:251-259
9. Schurmann G, Betzler M, Post S, Herfarth CH, Meuer S 1992 Soluble interleukin-2 receptor, interleukin-6 and interleukin-1β in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations. Digestion 51:51-59
10. Kirman I, Nielsen OH, Kjaersgaard E, Brynskov J 1995 Interleukin-2 receptor α and β chain expression by circulating αβ and γδ T cells in inflammatory bowel disease. Dig Dis Sci 40:291-295
11. Louis E, Belaiche J, Van Kemseke C, Schaaf N, Mahieu P, Mary JY 1995 Soluble interleukin-2 receptor in Crohn's disease. Assessment of disease activity and prediction of relapse. Dig Dis Sci 40:1750-1756
12. Brynskov J, Tvede N, Andersen CB, Vilien M 1992 Increased concentrations of interleukin 1β, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut 33:55-58
13. Matsuura T, West G, Youngman K, Klein J, Fiocchi C 1993 Immune activation genes in inflammatory bowel disease. Gastroenterology 104:448-458
14. Fehniger T, Caligiuri M 2001 Interleukin 15: biology and relevance to human disease. Blood 97:14-32
15. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson M, Watson J, Anderson D, Giri J 1994 Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965-968
16. Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K, Caligiuri MA 1995 Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J Clin Invest 96:2578-2582
17. Doherty TM, Seder RA, Sher A 1996 Induction and regulation of IL-15 expression in murine macrophages. J Immunol 156:735-741
18. Reinecker HC, MacDermott RP, Mirau S, Dignass A, Podolsky K 1996 Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 111:1706-1713
19. Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA 1996 IL-15 a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4:329-336
20. Kirman I, Nielsen OH 1996 Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am J Gastroenterol 91:1789-1794
21. Liu Z, Geboes K, Colpaert S, Haens G, Rutgeerts P, Ceuppens J 2000 IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J Immunol 164:3608-3615
22. Sakai T, Kusugami K, Nishimura H, Ando T, Yamaguchi T, Ohsuga M, Ina K, Enomoto A, Kimura Y, Yoshikai Y 1998 Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. Gastroenterology 114:1237-1243
23. Vainer B, Nielsen OH, Hendel J, Horn T, Kirman I 2000 Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease. Cytokine 12:1531-1536
24. Flamand L, Stefanescu I, Menezes J 1996 Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J Clin Invest 97:1373-1381
25. Fawaz L, Sharif-Askari E, Menezes J 1999 Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study. J Immunol 163:4473-4480
26. Guidotti L, Chisari F 2001 Noncytolytic control of viral infections by the innate and adaptative immune response. Annu Rev Immunol 19:65-91
27. Le Page C, Genin P, Baines MG, Hiscott J 2000 Interferon activation and innate immunity. Rev Immunogenet 2:374-386
28. Waldman T, Tagaya Y 1999 The multifaceted regulation of IL-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 17:19-49
29. Balfour S 1995 Microbial agents in the pathogenesis, differential diagnosis, and complications of inflammatory bowel diseases. In: Blaser M, Smith P, Ravdin J, Greenberg H, Guerrant R (eds) Infections of the Gastrointestinal Tract. Raven Press Ltd, New York, pp 435-458
30. Cottone M, Pietrosi G, Martorana G, Casa A, Pecoraro G, Oliva L, Orlando A, Rosselli M, Rizzo A, Pagliaro L 2001 Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 96:773-775
31. Wakefield A, Fox J, Sawyerr A, Taylor JE, Sweenie CH, Smith M, Emery VC, Hudson M, Tedder RS, Pounder RE 1992 Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol 38:183-190
32. Spieker T, Herbst H 2000 Distribution and phenotype of Epstein-Bar virus-infected cells in inflammatory bowel disease. Am J Pathol 157:51-57
33. Yanai H, Shimizu N, Nagasaki S, Mitani N, Okita K 1999 Epstein-Barr virus infection of the colon with inflammatory bowel disease. Am J Gastroenterology 94:1582-1586
34. Wakefield A, Pittilo R, Sim R, Cosby SL, Stephenson JR, Dhillon AP, Pounder RE 1993 Evidence of persistent measles virus infection in Crohn's disease. J Med Virol 39:345-353
35. Haga Y, Funakoshi O, Kuroe K, Kanazawa K, Nakajima H, Saito H, Murata Y, Munakata A, Yoshida Y 1996 Absence of measles viral genomic sequence in intestinal tissue from Crohn's disease by nested polymerase chain reaction. Gut 38:211-215
36. Harvey RF, Bradshaw JM 1980 A simple index of Crohn's disease activity. Lancet 1:514
37. Van Hees P, Van Elteren PH, Van Lier HJJ, Van Tongeren JH 1980 An index of inflammatory activity in patients with Crohn's disease. Gut 21:279-286
38. Riddell RH 1997 Histopathology of ulcerative colitis. In: Allan R, Rhodes J, Hanauer S, Keighley M, Alexander-Williams J, Fazio V (eds) Inflammatory Bowel Disease, 3rd ed. Churchill-Livingstone, Edinburgh, pp 291-309
39. Goldblum J, Petras R 1997 Histopathology of Crohn's disease. In: Allan R, Rhodes J, Hanauer S, Keighley M, Alexander-Williams J, Fazio V (eds) Inflammatory Bowel Disease, 3rd ed. Churchill-Livingstone, Edinburgh, pp 311-316
40. Eliakim R, Rachmilewitz D 1997 Assessing disease activity in Crohn's disease - are we there yet? Eur J Gastroenterol Hepatol 9:929-930
41. Modigliani R, Mary J, Simon J, Cortot A, Soule JC, Gendre JP, Rene E 1990 Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Gastroenterology 98:811-818
42. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M 1990 Predictability of the postoperative course of Crohn's disease. Gastroenterology 99:956-963
43. Otley A, Loonen H, Parekh N, Corey M, Sherman P, Griffiths A 1999 Assessing activity of pediatric Crohn's disease: which index to use? Gastroenterology 116:527-531
44. Waldmann T, Tagaya Y, Bamford R 1998 Interleukin-2, interleukin-15 and their receptors. Intern Rev Immunol 16:205-226
45. Reimund J, Wttersheim C, Dumont S, Muller C, Baumann R, Poindron P, Duclos B 1996 Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J Clin Immunol 16:144-150
46. Dionne S, D Agata D, Hiscott J, Vanounou T, Seidman E 1998 Colonic explant production of IL-1 and its receptor antagonist is imbalanced in inflammatory bowel disease. Clin Exp Immunol 112:435-442
47. Dionne S, Ruemmele F, Laberge S, Seidman E 2000 The effect of inflammation severity and of treatment on the production and release of TNFα by colonic explants in inflammatory bowel disease. Aliment Pharmacol Ther 14:1435-1442
48. Masuyama T, Matsuo M, Ichimaru T, Ishii K, Tsuchiya K, Hamasaki Y 2002 Possible contribution of interferon-alpha to febrile seizures in influenza. Pediatr Neurol 27:289-292